Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Learn what a financial index represents, including how it aggregates prices or values to reflect broader market movements.
21,406 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
host mike rowe slams the college-first script as earnings in the trades rise, with data center electricians pulling i...
Inflation can squeeze many businesses, but some companies thrive by design. This article makes the case for Visa as t...
Morgan Stanley files an amended S-1 for MSBT, signaling a concerted push to launch a spot Bitcoin ETF and disrupt the...
Lululemon has faced headwinds after a peak stretch. This article outlines whether lululemon stock recover? is feasibl...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...
Mark Cuban envisions AI enabling workers to finish earlier without a pay cut, a bold bet that could reshape budgets, ...
TD Cowen warns that bills advancing prediction markets face a tough path in Congress this year, citing bipartisan con...
A budget deal would fund most Homeland Security programs, including TSA, while leaving ICE operations unfunded. The m...
Analysts say cheap power, vast manufacturing, and a surge in open-source AI development could make China the big winn...